Company news

AdAlta Ltd. news in 2024

AdAlta Ltd.'s news releases, calls and decks from 2024, newest first.

View company

AD-214 clinical advisory board

October 9, 2024

FY24 RDTI Refund Received $1.77m

October 3, 2024

Transaction, investment facility update

September 2, 2024

$1.9 million raised from exercise of 1ADOA options

June 2, 2024

Cellular immunotherapy manufacturer secured - Cell Therapies

May 12, 2024

Extension of Victorian Government RDTI Loan Facility

April 28, 2024

Institutional investment to pursue strategic initiatives

April 28, 2024

SYNBV MoU Webinar presentation

April 9, 2024

SYNThesis BioVentures MoU for cellular immunotherapies

April 7, 2024

Corporate Presentation

March 7, 2024

Positive AD-214 Phase I extension study results

March 5, 2024

January 2024 partnering presentations and progress

January 21, 2024

Decks in 2024